BB BIOTECH (Switzerland) Today

Equity ratings for BB BIOTECH N are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of July 2021 and ending today, the 1st of August 2021. Click here to learn more.
BB BIOTECH N cannot be verified against its exchange. It appears that BB BIOTECH is not available for investing at the moment. Please verify the symbol is currently traded on Switzerland Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

BB BIOTECH Stock Profile

BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. BB Biotech AG was formed on November 09, 1993 and is domiciled in Switzerland. BB BIOTECH operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange.. The public information regarding BB BIOTECH N's current market price is not available at this time.
BB BIOTECH N is not yet fully synchronised with the market data
BB BIOTECH N has some characteristics of a very speculative penny stock
Legal NameBB BIOTECH N
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of BB BIOTECH's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Not RatedUndervalued
BB BIOTECH N (BION) is traded on Switzerland Exchange in Switzerland . The company currently falls under 'Mid-Cap' category with current market capitalization of 3.53 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BB BIOTECH's market, we take the total number of its shares issued and multiply it by BB BIOTECH's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. BB BIOTECH N operates under Healthcare sector and is part of Biotechnology industry. The entity has 55.4 M outstanding shares. BB BIOTECH N has accumulated about 3.64 B in cash with 140.41 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 65.76.
Check BB BIOTECH Probability Of Bankruptcy

BB BIOTECH Stock Against Markets

Picking the right benchmark for BB BIOTECH stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BB BIOTECH stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BB BIOTECH is critical whether you are bullish or bearish towards BB BIOTECH N at a given time.
BB BIOTECH N cannot be verified against its exchange. It appears that BB BIOTECH is not available for investing at the moment. Please verify the symbol is currently traded on Switzerland Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BB BIOTECH stock to make a market-neutral strategy. Peer analysis of BB BIOTECH could also be used in its relative valuation, which is a method of valuing BB BIOTECH by comparing valuation metrics with similar companies.
Check out Trending Equities. Note that the BB BIOTECH N information on this page should be used as a complementary analysis to other BB BIOTECH's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Tools for BB BIOTECH Stock

When running BB BIOTECH N price analysis, check to measure BB BIOTECH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB BIOTECH is operating at the current time. Most of BB BIOTECH's value examination focuses on studying past and present price action to predict the probability of BB BIOTECH's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BB BIOTECH's price. Additionally, you may evaluate how the addition of BB BIOTECH to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go